GGrantIndex
← Leaderboards

David M. Rapoport

New York University School Of Medicine

$2,355,523
Attributed
$2,545,648
Total exposure
14
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $253.5K · FY200523
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$2,545,648 · 14

By mechanism

U01$1,919,151 · 1
R21$380,250 · 1
M01$246,247 · 12

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectClinical ResearchPolysomnographySleep DisordersRespiratory Airflow DisorderSleep ApneaRespiratory Disorder DiagnosisHypertensionComorbidityFundingSleepUnited States National Institutes Of HealthPatient Monitoring DeviceDiagnosis Design /EvaluationPulmonary RespirationHourEnvironmentAssistive Device /TechnologyEvaluation /TestingBiomedical Equipment DevelopmentArousalElectroencephalographyControlled EnvironmentCardiovascular Function

Grant awards (32)

Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index$126,750
R21 · FY2023 · HL
Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index$126,750
R21 · FY2023 · HL
Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index$126,750
R21 · FY2022 · HL
AUTO CPAP BASED ON ENERGY SPECTRUM ANALYSIS OF FLOW FOR TREATMENT OF OSAS$5,504
M01 · FY2008 · RR · contact PI
IMPACT OF CPAP ON FUNCTIONAL OUTCOMES IN MILDER OSA$5,037
M01 · FY2008 · RR · contact PI
EFFECT OF NASAL RESISTANCE ON DELIVERED CPAP IN TREATING OSA$2,518
M01 · FY2008 · RR · contact PI
IMPACT OF CPAP ON FUNCTIONAL OUTCOMES IN MILDER OSA$32,074
M01 · FY2007 · RR · contact PI
IMPACT OF CPAP ON FUNCTIONAL OUTCOMES IN MILDER OSA$25,251
M01 · FY2006 · RR · contact PI
SKIN TEMPERATURE CHANGES TO DETECT SLEEP ONSET IN UNMONITORED SLEEP STUDIES$10,528
M01 · FY2005 · RR
Comparison of Minimal to Full Polysomnography for the Diagnosis of OSAHS$81,311
M01 · FY2004 · RR
SLEEP HEART HEALTH STUDY$328,088
U01 · FY2003 · HL
SLEEP HEART HEALTH STUDY$480,086
U01 · FY2002 · HL
COMPUTER CONTROLLED NASAL CPAP FOR OSAS$0
M01 · FY2002 · RR
ACTIGRAPHY AND POLYSOMNOGRAPHY IN ASTHMA$0
M01 · FY2002 · RR
ORAL APPLIANCE THERAPY FOR UPPER AIRWAY RESISTANCE SYNDROME$0
M01 · FY2002 · RR
CARDIOVASCULAR CONSEQUENCES OF SLEEP RELATED BREATHING DISORDERS$0
M01 · FY2002 · RR
SLEEP HEART HEALTH STUDY$637,210
U01 · FY2001 · HL
ORAL APPLIANCE THERAPY FOR UPPER AIRWAY RESISTANCE SYNDROME$0
M01 · FY2001 · RR
CARDIOVASCULAR CONSEQUENCES OF SLEEP RELATED BREATHING DISORDERS$0
M01 · FY2001 · RR
ACTIGRAPHY AND POLYSOMNOGRAPHY IN ASTHMA$0
M01 · FY2001 · RR
COMPUTER CONTROLLED NASAL CPAP FOR OSAS$0
M01 · FY2001 · RR
SLEEP HEART HEALTH STUDY$473,767
U01 · FY2000 · HL
COMPUTER CONTROLLED NASAL CPAP FOR OSAS$21,006
M01 · FY2000 · RR
ACTIGRAPHY AND POLYSOMNOGRAPHY IN ASTHMA$21,006
M01 · FY2000 · RR
CARDIOVASCULAR CONSEQUENCES OF SLEEP RELATED BREATHING DISORDERS$21,006
M01 · FY2000 · RR
ORAL APPLIANCE THERAPY FOR UPPER AIRWAY RESISTANCE SYNDROME$21,006
M01 · FY2000 · RR
COMPUTER CONTROLLED NASAL CPAP FOR OSAS$0
M01 · FY2000 · RR
ACTIGRAPHY AND POLYSOMNOGRAPHY IN ASTHMA$0
M01 · FY2000 · RR
ORAL APPLIANCE THERAPY FOR UPPER AIRWAY RESISTANCE SYNDROME$0
M01 · FY2000 · RR
NASAL CANNULA/PRESSURE TRANSDUCER RESPIRATION IN THE ICU$0
M01 · FY2000 · RR
NASAL CANNULA/PRESSURE TRANSDUCER RESPIRATION IN THE ICU$0
M01 · FY2000 · RR
CARDIOVASCULAR CONSEQUENCES OF SLEEP RELATED BREATHING DISORDERS$0
M01 · FY2000 · RR